Clinical trials

  • ADRC001 for Hypertrophic scarring
  • EVEROLIMUS for Diffuse intrinsic pontine glioma (DIPG) | Diffuse midline glioma (H3K28M-mutant or EZHIP-positive)
  • LITIFILIMAB for Systemic lupus erythematosus
  • trastuzumab deruxtecan for Metastatic HER2-positive breast cancer
  • aHyC-TNBC for Triple negative breast cancer
  • N/A for Underweight
  • LUTIKIZUMAB for Ulcerative colitis
  • IRON OXIDE, NANOPARTICLES for Rectal cancer | Mesorectal lymph node metastases
  • ALXN1850 for Hypophosphatasia
  • Clinical trial in Triple negative breast cancer
  • COLCHICINE for Acute myocarditis
  • PEMBROLIZUMAB for Melanoma | Renal cell carcinoma | Non-small cell lung cancer